ImpediMed Limited (IPD.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.14 Million AUD | -21.01% |
| 2023 | 1.44 Million AUD | 751.18% |
| 2022 | 170 Thousand AUD | -64.14% |
| 2021 | 474 Thousand AUD | -45.58% |
| 2020 | 871 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 64.02 Thousand AUD | -91.74% |
| 2007 | 775.44 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.27 Million AUD | 0.0% |
| 2024 Q4 | 1.14 Million AUD | 0.0% |
| 2024 FY | 1.14 Million AUD | -21.01% |
| 2023 Q2 | 1.32 Million AUD | 0.0% |
| 2023 Q4 | 1.44 Million AUD | 0.0% |
| 2023 FY | 1.44 Million AUD | 751.18% |
| 2022 Q2 | 322 Thousand AUD | 0.0% |
| 2022 Q4 | 170 Thousand AUD | 0.0% |
| 2022 FY | 170 Thousand AUD | -64.14% |
| 2021 FY | 474 Thousand AUD | -45.58% |
| 2021 Q4 | 474 Thousand AUD | 0.0% |
| 2021 Q2 | 647 Thousand AUD | 0.0% |
| 2020 FY | 871 Thousand AUD | 0.0% |
| 2020 Q2 | 833 Thousand AUD | 0.0% |
| 2020 Q4 | 871 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2008 FY | 64.02 Thousand AUD | -91.74% |
| 2008 Q4 | 64.02 Thousand AUD | 0.0% |
| 2007 FY | 775.44 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 77.678% |
| Adherium Limited | 93.2 Thousand AUD | -1126.329% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 83.232% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -1249.947% |
| Anteris Technologies Ltd | 2.33 Million AUD | 51.005% |
| Control Bionics Limited | 961.73 Thousand AUD | -18.847% |
| CardieX Limited | 3.22 Million AUD | 64.588% |
| Compumedics Limited | 6.97 Million AUD | 83.618% |
| Cochlear Limited | 243.7 Million AUD | 99.531% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 66.834% |
| Cyclopharm Limited | 4.22 Million AUD | 72.961% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 60.59% |
| Nova Eye Medical Limited | 3.34 Million AUD | 65.87% |
| HeraMED Limited | 260.65 Thousand AUD | -338.509% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 92.72% |
| InhaleRx Limited | 560.27 Thousand AUD | -104.007% |
| LBT Innovations Limited | 1.74 Million AUD | 34.423% |
| Micro-X Limited | 4.05 Million AUD | 71.813% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -1517.331% |
| PolyNovo Limited | 15.38 Million AUD | 92.568% |
| Respiri Limited | 1.17 Million AUD | 2.853% |
| SomnoMed Limited | 1.01 Million AUD | -12.499% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 77.009% |
| Uscom Limited | 989.27 Thousand AUD | -15.539% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -266.163% |